Jagsonpal Pharmaceuticals Ltd

NSE: JAGSNPHARM · BSE: 507789 · Pharmaceuticals & Biotechnology · 8 announcements

Share price: ₹242.29
Market cap: ₹1,598 Cr
Revenue (annual): ₹287.2 Cr
Net profit (annual): ₹43.08 Cr
P/E (TTM): 35.1×Sector 50.4×
Promoter holding: 69.05%+1.16% QoQ
FII holding: 2.30%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

23 Sep 2026 17:52 IST BSE

Acquisition

Jagsonpal Pharmaceuticals Acquisition Worth ₹46.7 Cr

Jagsonpal Pharmaceuticals Ltd will acquire the Wellness Portfolio of Group Pharmaceuticals Ltd. The transaction involves a total consideration capped at ₹46.7 Crore.

Value: ₹46.70 Cr

Read the filing ↗